1. STAT+: Cell Therapy Shows Early Promise to End Lifelong Anti-Rejection Drugs for Liver Transplant Patients
A small, early-stage study has demonstrated a potential path to the 'holy grail' of transplant medicine: immune tolerance. The research suggests that using cells from living liver donors could 'teach' a recipient's immune system to accept the foreign organ as its own, potentially eliminating the need for lifelong, risk...